Steatohepatitis

Search with Google Search with Bing
Information
Disease name
Steatohepatitis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00326482 Active, not recruiting Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy July 31, 2006
NCT02378259 Active, not recruiting N/A Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity August 15, 2014 June 2034
NCT04063826 Active, not recruiting N/A PET-MR Study of Fatty Liver April 10, 2018 December 31, 2023
NCT05946330 Active, not recruiting N/A Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). February 22, 2023 July 31, 2024
NCT00886301 Completed N/A Fatty Liver and Ectopic Fat in Overweight and Obese Patients March 2010 October 2, 2014
NCT01147523 Completed Phase 2 Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease January 2010 December 2011
NCT01154985 Completed Phase 2 Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) June 2010 October 2012
NCT01645852 Completed N/A A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection June 2012 December 2016
NCT02009592 Completed N/A Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients June 2013 February 2014
NCT03915002 Completed Integrated Approaches for Identifying Molecular Targets in Liver Disease June 13, 2019 April 12, 2023
NCT00512512 Completed Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass June 2007 June 2009
NCT00575757 Completed Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV July 2007 July 2016
NCT01476995 Completed Prognostic Indicators as Provided by the EPIC ClearView September 2010 June 2011
NCT01556113 Completed N/A Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease March 2012 February 2017
NCT05640947 Recruiting N/A Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass January 30, 2023 February 2026
NCT05864391 Terminated Phase 1 A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. March 31, 2023 March 20, 2024
NCT01523639 Terminated Phase 2 A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis April 2012 April 2014
NCT01246388 Unknown status Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy May 2010 December 2014
NCT00914446 Unknown status N/A Identification of Protective and Worsening Steatohepatitis (NASH) Factors April 2008 April 2010